SCHEMBL4217673

SCHEMBL4217673

Cc1cnccc1C1CNC(=O)O1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PKM P14618 1/20 0.38
LMNA P02545 2/20 0.35
MAOA P21397 1/20 0.35
SLC6A2 P23975 1/20 0.35
OPRL1 P41146 2/20 0.34
USP2 O75604 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
CYP17A1 P05093 3/20 0.33
PDE3B Q13370 2/20 0.33
PDE3A Q14432 2/20 0.33
CYP11B1 P15538 1/20 0.33
CYP11B2 P19099 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
ADORA2A P29274 1/20 0.33
IDO1 P14902 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13394483 0.79 PKM (0.50) PKMLMNAMAOASLC6A2USP2
SCHEMBL22463649 0.74 OPRL1 (0.40) OPRL1CYP17A1CYP11B1CYP11B2ADORA3
SCHEMBL12480396 0.74 OPRL1 (0.40) OPRL1CYP17A1CYP11B1CYP11B2ADORA3
SCHEMBL13547538 0.73 DDB1 (0.39) PKMLMNAUSP2ALDH1A1HPGD
SCHEMBL28680491 0.71 OPRL1 (0.44) OPRL1CYP17A1CYP11B1CYP11B2IDO1
SCHEMBL28680489 0.71 OPRL1 (0.44) OPRL1CYP17A1CYP11B1CYP11B2IDO1
SCHEMBL29368373 0.71 OPRL1 (0.44) OPRL1CYP17A1CYP11B1CYP11B2IDO1
SCHEMBL5021231 0.71 CHRNB2 (0.46) CYP11B1CYP11B2
SCHEMBL10243298 0.71 CHRNB2 (0.46) CYP11B1CYP11B2
SCHEMBL9243943 0.68 MAOB (0.44) PKMLMNAMAOASLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029560-A2 1,3-OXAZOLIDIN-2-ONE DERIVATIVES USEEFUL AS CETP INHIBITORS Merck & Co., Inc. (US) 2009-03-04 EP disclosed
WO-2007079186-A2 1, 3-OXAZOLIDIN-2-ONE DERIVATIVES USEFUL AS CETP INHIBITORS MERCK & CO., INC. (US) 2007-07-12 WO disclosed